Management of Transient Ischemia Attacks in the Twenty-First Century

Emergency Medicine Clinics of North America

Volumn 27, Issue 1, 2009, Pages 51-69

  Ross, Michael ^a   Nahab, Fadi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Management; Stroke; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; INFUSION FLUID; IRBESARTAN; LOW MOLECULAR WEIGHT HEPARIN; NIMODIPINE; SIMVASTATIN; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN;

ANAMNESIS; ANTICOAGULANT THERAPY; ARTERY DISSECTION; BACTERIAL ENDOCARDITIS; BLEEDING; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DRUG EFFICACY; ECHOCARDIOGRAPHY; ECHOGRAPHY; EMERGENCY WARD; HEADACHE; HEART ATRIUM FIBRILLATION; HIGH RISK PATIENT; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MONOTHERAPY; NEUROIMAGING; NEUTROPENIA; OUTPATIENT DEPARTMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENCE RISK; RETINA ISCHEMIA; REVIEW; RISK REDUCTION; STROKE; SYMPTOMATOLOGY; TRANSIENT ISCHEMIC ATTACK; VERTEBRAL ARTERY;

EID: 59849100952     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2008.08.008     Document Type: Review

References (78)

1. Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III. Stroke 21 (1990) 637-676
2. Dyken M.I., Conneally M., Haerer A.F., et al. Cooperative study of hospital frequency and character of transient ischemic attacks, I: background, organization and clinical surgery. JAMA 237 (1977) 882-886
3. Albers G.W., Caplan L.R., and Easton J.D. Transient ischemic attack-proposal for a new definition. N Engl J Med 347 (2002) 1713-1716
4. Hankey G.J. Impact of treatment of people with transient ischemic attack on stroke incidence and public health. Cerebrovasc Dis 6 Suppl 1 (1996) 26-33
5. Rothwell P.M., and Warlow C.P. Timing of TIAs preceding stroke: time window for prevention is very short. Neurology 64 (2005) 817-820
6. Available at: www.nihstrokescale.org or professionaleducationcenter.americanheart.org.
7. Johnston S.C., Gress D.R., Browner W.S., et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA 284 (2000) 2901-2906
8. Coull A.J., Lovett J.K., and Rothwell P.M. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ 328 (2004) 326-328
9. Daffertshofer M., Mielke O., Pullwitt A., et al. Transient ischemic attacks are more than "ministrokes.". Stroke 35 (2004) 2453-2458
10. Gladstone D.J., Kapral M.K., Fang J., et al. Management and outcomes of transient ischemic attacks in Ontario. CMAJ 170 (2004) 1099-1104
11. Rothwell P.M., Giles M.F., Flossmann E., et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 366 (2005) 29-36
12. Johnston S.C., Rothwell P.M., Nguyen-Huynh M.N., et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369 (2007) 283-292
13. Tsivgoulis G., Spengos K., Manta P., et al. Validation of the ABCD score in identifying individuals at high early risk of stroke after a transient ischemic attack: a hospital-based case series study. Stroke 37 (2006) 2892-2897
14. Tsivgoulis G., Vassilopoulou S., and Spengos K. Potential applicability of ABCD score in triaging TIA patients. Lancet 369 (2007) 1082
15. Cucchiara B.L., Messe S.R., Taylor R.A., et al. Is the ABCD score useful for risk stratification of patients with acute transient ischemic attack?. Stroke 37 (2006) 1710-1714
16. Redgrave J.N., Coutts S.B., Schulz U.G., et al. Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. Stroke 38 (2007) 1482-1488
17. Purroy F., Montaner J., Rovira A., et al. Higher risk of further vascular events among transient ischemic attack patients with diffusion-weighted imaging acute ischemic lesions. Stroke 35 (2004) 2313-2319
18. Coutts S.B., Simon J.E., Eliasziw M., et al. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol 57 (2005) 848-854
19. Boulanger J.M., Coutts S.B., Eliasziw M., et al. Diffusion-weighted imaging-negative patients with transient ischemic attack are at risk of recurrent transient events. Stroke 38 (2007) 2367-2369
20. Redgrave J.N., Schulz U.G., Briley D., et al. Presence of acute ischaemic lesions on diffusion-weighted imaging is associated with clinical predictors of early risk of stroke after transient ischaemic attack. Cerebrovasc Dis 24 (2007) 86-90
21. Calvet D., Lamy C., Touze E., et al. Management and outcome of patients with transient ischemic attack admitted to a stroke unit. Cerebrovasc Dis 24 (2007) 80-85
22. Eliasziw M., Kennedy J., Hill M.D., et al. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ 170 (2004) 1105-1109
23. Purroy F., Molina C.A., Montaner J., et al. Absence of usefulness of ABCD score in the early risk of stroke of transient ischemic attack patients. Stroke 38 (2007) 855-856 [author reply 857]
24. Johnston S.C., Nguyen-Huynh M.N., Schwarz M.E., et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 60 (2006) 301-313
25. Nguyen-Huynh M.N., and Johnston S.C. Is hospitalization after TIA cost-effective on the basis of treatment with TPA?. Neurology 65 (2005) 1799-1801
26. Poisson S.N., Lisabeth L.D., Brown D.L., et al. Effect of hospital admission on stroke risk following TIA. Neurology 68 Suppl 1 (2007) A193
27. Rothwell P.M., Giles M.F., Chandratheva A., et al. Early Use of Existing Strategies for Stroke (EXPRESS) study. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 370 (2007) 1432-1442
28. Lavallée P.C., Mesequer E., Abboud H., et al. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol 6 (2007) 953-960
29. Goldstein L.B., Bian J., Samsa G.P., et al. New transient ischemic attack and stroke: outpatient management by primary care physicians. Arch Intern Med 160 (2000) 2941-2946
30. Mace S.E., Graff L., Mikhail M., et al. A national survey of observation units in the United States. Am J Emerg Med 21 (2003) 529-533
31. Roberts R.R., Zalenski R.J., Mensah E.K., et al. Costs of an emergency department-based accelerated diagnostic protocol vs hospitalization in patients with chest pain: a randomized controlled trial. JAMA 278 (1997) 1670-1676
32. Gomez M.A., Anderson J.L., Karagounis L.A., et al. An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO). J Am Coll Cardiol 28 (1996) 25-33
33. Ross M.A., Compton S., Medado P., et al. An emergency department diagnostic protocol for patients with transient ischemic attack: a randomized controlled trial. Ann Emerg Med 50 (2007) 109-119
34. Krol A.L., Coutts S.B., Simon J.E., et al., for the VSG. Perfusion MRI abnormalities in speech or motor transient ischemic attack patients. Stroke 36 (2005) 2487-2489
35. Wojner-Alexander A.W., Garami Z., Chernyshev O.Y., et al. Heads down: flat positioning improves blood flow velocity in acute ischemic stroke. Neurology 64 (2005) 1354-1357
36. Ahmed N., and Wahlgren N.G. Effects of blood pressure lowering in the acute phase of total anterior circulation infarcts and other stroke subtypes. Cerebrovasc Dis 15 (2003) 235-243
37. Oliveira-Filho J., Silva S.C., Trabuco C.C., et al. Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset. Neurology 61 (2003) 1047-1051
38. Sherman D.G., Albers G.W., Bladin C., et al. The efficacy and safety of enoxaparin vs. unfractionated heparin for the Prevention of Venous Thromboembolism After Acute Ischaemic Stroke (PREVAIL study): an open-label randomised comparison. Lancet 369 (2007) 1347-1355
39. Johnston S.C., Leira E.C., Hansen M.D., et al. Early recovery after cerebral ischemia risk of subsequent neurological deterioration. Ann Neurol 54 (2003) 439-444
40. Wiebers D.O., Whisnant J.P., and O'Fallon W.M. Reversible ischemic neurologic deficit (RIND) in a community: Rochester, Minnesota, 1955-1974. Neurology 32 (1982) 459-465
41. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349 (1997) 1569-1581
42. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 349 (1997) 1641-1649
43. Chen Z.M., Sandercock P., Pan H.C., et al. Indications for early aspirin use in acute ischemic stroke: a combined analysis of 40,000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial. On behalf of the CAST and IST collaborative groups. Stroke 31 (2000) 1240-1249
44. Kennedy J., Hill M.D., Ryckborst K.J., et al. Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol 6 (2007) 961-969
45. Biller J., Bruno A., Adams H.P., et al. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study. Stroke 20 (1989) 441-447
46. Putnam S.F., and Adams H.P. Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol 42 (1985) 960-962
47. Keith D.S., Phillips S.J., Whisnant J.P., et al. Heparin therapy for recent transient focal cerebral ischemia. Mayo Clin Proc 62 (1987) 1101-1106
48. Berge E., and Sandercock P. Anticoagulants vs. antiplatelet agents for acute ischaemic stroke. Cochrane Database Syst Rev (2002) CD003242
49. Hacke W., Donnan G., Fieschi C., et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363 (2004) 768-774
50. Rothwell P.M., Eliasziw M., Gutnikov S.A., et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 363 (2004) 915-924
51. Alamowitch S., Eliasziw M., Algra A., et al. Risk, causes, and prevention of ischaemic stroke in elderly patients with symptomatic internal-carotid-artery stenosis. Lancet 357 (2001) 1154-1160
52. Hart R.G., Pearce L.A., and Aguilar M.I. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146 (2007) 857-867
53. Connolly S., Pogue J., Hart R., et al. Clopidogrel plus aspirin vs. oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 367 (2006) 1903-1912
54. Berge E., Abdelnoor M., Nakstad P.H., et al. Low molecular-weight heparin vs. aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study. HAEST Study Group. Heparin in Acute Embolic Stroke Trial. Lancet 355 (2000) 1205-1210
55. Lyrer P., and Engelter S. Antithrombotic drugs for carotid artery dissection. Cochrane Database Syst Rev (2003) CD000255
56. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
57. Serebruany V.L., Steinhubl S.R., Berger P.B., et al. Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials. Am J Cardiol 95 (2005) 1218-1222
58. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
59. Hass W.K., Easton J.D., Adams H.P., et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 321 (1989) 501-507
60. Gent M., Blakely J.A., Easton J.D., et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1 (1989) 1215-1220
61. Gorelick P.B., Richardson D., Kelly M., et al. Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA 289 (2003) 2947-2957
62. Diener H.C., Cunha L., Forbes C., et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 (1996) 1-13
63. Halkes P.H., van Gijn J., Kappelle L.J., et al. Aspirin plus dipyridamole vs. aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 367 (2006) 1665-1673
64. Diener H.C., Bogousslavsky J., Brass L.M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
65. Bhatt D.L., Fox K.A., Hacke W., et al. Clopidogrel and aspirin vs. aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
66. Diener H.C., Sacco R., Yusuf S., and for Steering Committee and PRoFESS Study Group. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan vs. placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS). Cerebrovasc Dis 23 (2007) 368-380
67. Sacco R.L., Adams R., Albers G., et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37 (2006) 577-617
68. Albers G.W., Amarenco P., Easton J.D., et al. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 483S-512S
69. Adams R.J., Albers G., Alberts M.J., et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 39 (2008) 1647-1652
70. Collins R., Armitage J., Parish S., et al. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 363 (2004) 757-767
71. Amarenco P., Bogousslavsky J., Callahan III A., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355 (2006) 549-559
72. Briel M., Schwartz G.G., Thompson P.L., et al. Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials. JAMA 295 (2006) 2046-2056
73. Aronow H.D., Novaro G.M., Lauer M.S., et al. In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis. Arch Intern Med 163 (2003) 2576-2582
74. Cucchiara B., and Kasner S.E. Use of statins in CNS disorders. J Neurol Sci 187 (2001) 81-89
75. Goldstein L.B., and Investigators S.P.A.R.C.L. The SPARCL trial: effect of statins on stroke severity. Ann Neurol 60 Suppl 10 (2006) S85
76. Progress Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
77. Adams Jr. H.P., del Zoppo G., Alberts M.J., et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115 (2007) e478-e534
78. Cucchiara B., and Ross M. Transient ischemic attack: risk stratification and treatment. Ann Emerg Med 52 (2008) S27-S39